18 THUMBS UP: FDA advisers vote 18-4 to recommend the agency approve sales of lorcaserin, which could be the country's first new prescription diet drug in over a decade.
STOCK SURGE: Shares nearly doubled in after-hours trading, as lorcaserin could become the small company's first approved product.
NEXT STEPS: Maker Arena Pharmaceuticals says it will work with the FDA as it finishes its review, with a June 27 target for a final decision. The agency had rejected lorcaserin in 2010 over possible heart risks, but Arena tried again with additional data.
Concealed Carrying AF Vet Held Back From Stopping Attack By UCC Staff
Russia's real game in Syria | RedState
Mia Farrow accidentally shows how little the NRA spends in D.C.
The truth about gun deaths: numbers and actual solutions
Dear 'Gun Free Zone' Campus Wizards: Nine Kids Died Because Of Your Stupid Policy
Dave Ramsey - On Swimming Pools, Car Payments, and Insurance
The War on America Turns 50 | Human Events